疏肝三两三方联合揿针治疗肝郁血瘀型经行头痛临床观察

Clinical Observation of Shugan Sanliangsan Prescription Combined with Press-Needle for Menstrual Headache with Syndrome of Liver Stagnation and Blood Stasis

目的:观察疏肝三两三方联合揿针治疗肝郁血瘀型经行头痛的临床疗效。方法:将61例肝郁血瘀型经行头痛患者按随机数字表法分为治疗组31例和对照组30例。治疗组予口服疏肝三两三方联合揿针治疗,对照组予口服盐酸氟桂利嗪胶囊治疗。观察2组临床疗效及头痛发作次数、头痛持续时间、视觉模拟评分法(VAS)评分、中医证候积分的变化,统计复发率。结果:治疗组总有效率87.1%,对照组总有效率60.0%,2组比较,差异有统计学意义(P<0.05)。治疗后及随访3月,2组头痛发作次数均较治疗前减少(P<0.05),头痛持续时间均较治疗前缩短(P<0.05),VAS评分均较治疗前下降(P<0.05);治疗组的头痛发作次数少于对照组(P<0.05),头痛持续时间短于对照组(P<0.05),VAS评分低于对照组(P<0.05)。治疗后及随访3月,2组中医证候积分均较治疗前降低(P<0.05),治疗组的中医证候积分低于对照组(P<0.05)。治疗组复发率11.1%(3/27),对照组复发率38.9%(7/18),2组比较,差异有统计学意义(P<0.05)。结论:疏肝三两三方联合揿针治疗肝郁血瘀型经行头痛,能有效缓解患者的头痛情况,效果优于口服盐酸氟桂利嗪胶囊。

Objective： To observe the clinical effect of Shugan Sanliangsan prescription combined with press-needle for menstrual headache with syndrome of liver stagnation and blood stasis. Methods： Divided 61 cases of menstrual headache patients with syndrome of liver stagnation and blood stasis into the treatment group being 31 cases and the control group being 30 cases according to the random table method. The treatment group was treated with oral Shugan Sanliangsan prescription combined with press-needle, while the control group was treated with oral Flunarizine hydrochloride capsules. Observed clinical curative effect, and change of headache rate, duration of headache, visual analogue scale（VAS） and Chinese medicine syndrome score, and recorded recurrence rate of both groups. Results： The total effective rate was 87.1% in the treatment group and was 60.0% in the control group, the difference being significant（P〈0.05）. After treatment and follow-up for three months, headache rate was decreased（P〈0.05）, duration of headache was shortened（P〈0.05）, VAS scores in both groups were decreased when compared with those before treatment（P〈0.05）.Headache rate of the treatment group was lower（P〈0.05）, duration of headache of the treatment group was shorter（P〈0.05）, VAS scores were lower when compared with those of the control group（P〈0.05）. Comparing with those before treatment, Chinese medicine syndrome scores were declined in both groups after treatment and follow-up for three months（P〈0.05）, and the scores of the treatment group were lower than those of the control group（P〈0.05）. Recurrence rate was 11.1%（3/27） in the treatment group and was 38.9%（7/18） in the control group, difference being significant（P〈0.05）. Conclusion： Shugan Sanliangsan prescription combined with press-needle can effectively relieve pain of patients, which has better efficacy than oral Flunarizine hydrochloride capsules in treating menstrual headache with syndrome of liver stagnation and blood stasis.